The role of purinergic receptors in the microglial inflammatory response has largely focused on P2X7, where it has been shown to modulate microglial activation following experimental brain ischemia and stroke, and its pharmacologic blockade led to decreased ischemic damage [2], [3], [4], [5]. Here, P2RX7 is linked to Stroke.